Table 2.
Resistance profile | All cases | |
---|---|---|
No. | % | |
Total resistance | 209 | 100 |
Monoresistance | 59 | 28.2 |
INH only | 37 | 17.7 |
RIF only | 13 | 6.1 |
SM only | 6 | 2.9 |
EMB only | 3 | 1.4 |
MDR | 122 | 58.4 |
INH+RIF | 23 | 11 |
INH+RIF+EMB | 14 | 6.7 |
INH+RIF+SM | 14 | 6.7 |
INH+RIF+SM+EMB | 71 | 34 |
Polyresistance* | 28 | 13.4 |
INH+SM+EMB | 14 | 6.7 |
INH+SM | 11 | 5.3 |
RIF+SM | 1 | 0.5 |
EMB+SM | 2 | 1 |
Overall resistant to | ||
INH drug | 204 | 97.6 |
RIF drugs | 136 | 65.1 |
SM drugs | 119 | 57 |
EMB drugs | 104 | 49.8 |
*Resistant to two or more drugs but not both isoniazid and rifampicin;
EMB=Ethambutol;
INH=Isoniazid;
MDRTB=Multi-drug-resistant tuberculosis (resistant to at least both isoniazid and rifampicin with or without resistance to other drugs);
RIF=Rifampicin;
SM=Streptomycin